Page last updated: 2024-10-30

metaproterenol and Abruptio Placentae

metaproterenol has been researched along with Abruptio Placentae in 1 studies

Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.

Abruptio Placentae: Premature separation of the normally implanted PLACENTA from the UTERUS. Signs of varying degree of severity include UTERINE BLEEDING, uterine MUSCLE HYPERTONIA, and FETAL DISTRESS or FETAL DEATH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Terlizzi, G1

Other Studies

1 other study available for metaproterenol and Abruptio Placentae

ArticleYear
[Use of Alupent in obstetrics. Our personal experiences].
    Minerva ginecologica, 1973, Volume: 25, Issue:4

    Topics: Abortion, Threatened; Abruptio Placentae; Dystocia; Female; Fetus; Heart; Homeostasis; Humans; Metap

1973